News
Asarina Pharma Clinical Trial featured on BBC
2019-04-23 08:35
“Why is PMDD so difficult to treat, and what help might a new trial offer to those who suffer?” Founded in 1946, ‘Woman’s Hour&rsquo...
Asarina Pharma Annual Report for 2018 released
2019-04-17 08:00
For further information see the attached, plus please visit www.asarinapharma.com For further information, please contact: Peter Nordkild, CEO, Asarina...
Asarina Pharma Proposals regarding the Board of Directors for the Annual General Meeting 2019
2019-04-11 14:26
- Number of directors: six (6) - Annual remuneration to the Board of Directors: SEK 500,000 to the Chairman of the Board and SEK 200,000...
NOTICE OF ANNUAL GENERAL MEETING IN ASARINA PHARMA AB (publ)
2019-04-05 10:30
Right to participate Those who have been recorded as shareholders in the share register kept by Euroclear Sweden AB as per May 2nd, 2019, and who, no later...
Asarina Pharma shows efficacy of Sepranolone in Tourette’s syndrome on par with current first line treatment, but without side effects
2019-04-02 08:00
The research group led by Prof. Marco Bortolato at the University of Utah has found that Sepranolone reduces the number of tic-like responses in the D1CT-7...
Asarina Pharma Year-End Report 2018 shows solid progress
2019-02-25 08:30
Fourth Quarter 2018: FINANCIAL HIGHLIGHTS We received SEK 6.3 million in October in proceeds from the green shoe connected to the IPO. We maintained strict...
Asarina Pharma Scientific Advisory Board gives full backing to Menstrual Migraine Phase IIA trial
2018-12-18 08:47
Migraine is more prevalent than diabetes, epilepsy and asthma combined, three times more women than men suffer from it, and 1-in-5 of those suffer from...
Asarina Pharma CSO presents at PMS event in Stockholm: ‘It’s time to talk about PMDD’
2018-11-22 17:15
The event began with Lisa Stenberg, author of the best-selling Bli vän med din PMS (Make friends with your PMS). Lisa emphasized the importance of...
Interim Report July-September 2018
2018-11-14 08:00
Third Quarter Highlights Key financials 1 July – 30 September 2018 - Net sales: SEK 0 (0) - Operating loss: SEK 14.6M (Loss: 3.6M) - Earnings per...
Asarina Pharma sponsors PMS Day Stockholm ‘Women’s health affects all of us, it’s time to talk about PMDD’
2018-10-24 10:26
On November 21 2018 Asarina Pharma CSO Torbjörn Bäckström and COO Karin Ekberg will join Swedish celebrities and scientists as they present...